Racial Differences in Sexuality Profiles among American, Japanese, and Japanese American Men with Localized Prostate Cancer

Journal of Sexual Medicine

Volumn 8, Issue 9, 2011, Pages 2625-2631

  Namiki, Shunichi ^a   Carlile, Robert G ^b   Namiki, Thomas S ^b   Fukagai, Takashi ^c   Takegami, Misa ^d,e   Litwin, Mark S ^f   Arai, Yoichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF HAWAII   (United States)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Erectile Dysfunction; Ethnicity; Prostate Cancer; Quality of Life; Race; Racial Differences in Sexual Function

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; ASIAN AMERICAN; CANCER STAGING; CAUCASIAN; COMORBIDITY; ETHNICITY; GLEASON SCORE; HUMAN; JAPANESE; LIBIDO; MAJOR CLINICAL STUDY; MALE; ORGASM; PENIS ERECTION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RACE DIFFERENCE; SEXUAL FUNCTION; SEXUALITY;

EID: 80052450134     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02362.x     Document Type: Article

References (35)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Cook LS, Goldoft M, Schwartz SM, Weiss NS. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 1999;161:152-5.
3. McCracken M, Olsen M, Chen MS Jr, Jemal A, Thun M, Cokkinides V, Deapen D, Ward E. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 2007;57:190-205.
4. Ramsey SD, Zeliadt SB, Hall IJ, Ekwueme DU, Penson DF. On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. J Urol 2007;177:1992-9.
5. Stephenson RA, Mori M, Hsieh YC, Beer TM, Stanford JL, Gilliland FD, Hoffman RM, Potosky AL. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: Patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study. J Urol 2005;174:646-50.
6. Miller DC, Wei JT, Dunn RL, Montie JE, Pimentel H, Sandler HM, McLaughlin PW, Sanda MG. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: Potential influence of sexual motivation and/or indifference. Urology 2006;68:166-71.
7. Shabsigh R, Perelman MA, Laumann EO, Lockhart DC. Drivers and barriers to seeking treatment for erectile dysfunction: A comparison of six countries. BJU Int 2004;94:1055-65.
8. Soloway CT, Soloway MS, Kim SS, Kava BR. Sexual, psychological and dyadic qualities of the prostate cancer "couple". BJU Int 2005;95:780-5.
9. Neese LE, Schover LR, Klein EA, Zippe C, Kupelian PA. Finding help for sexual problems after prostate cancer treatment: A phone survey of men's and women's perspectives. Psychooncology 2003;12:463-73.
10. Knoll N, Burkert S, Kramer J, Roigas J, Gralla O. Relationship satisfaction and erectile functions in men receiving laparoscopic radical prostatectomy: Effects of provision and receipt of spousal social support. J Sex Med 2009;6:1438-50.
11. Laumann EO, West S, Glasser D, Carson C, Rosen R, Kang JH. Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: From the male attitudes regarding sexual health survey. J Sex Med 2007;4:57-65.
12. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ; Urologic Diseases in America Project. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 2006;166:207-12.
13. Smith JF, Caan BJ, Sternfeld B, Haque R, Quesenberry CP Jr, Quinn VP, Shan J, Walsh TJ, Lue TF, Jacobsen SJ, Van den Eeden SK. Racial disparities in erectile dysfunction among participants in the California Men's Health Study. J Sex Med 2009;6:3433-9.
14. Zaridze DG, Boyle P, Smans M. International trends in prostatic cancer. Int J Cancer 1984;33:223-30.
15. Fukagai T, Namiki TS, Carlile RG, Yoshida H, Namiki M. Comparison of the clinical outcome after hormonal therapy for prostate cancer between Japanese and Caucasian men. BJU Int 2006;97:1190-3.
16. Namiki S, Kwan L, Kagawa-Singer M, Saito S, Terai A, Satoh T, Baba S, Arai Y, Litwin MS. Sexual function reported by Japanese and American men. J Urol 2008;179:245-9.
17. Namiki S, Kwan L, Kagawa-Singer M, Arai Y, Litwin MS. The effect of erectile function on the use of phosphodiesterase-5 inhibitors after radical prostatectomy in Japanese and U.S. men. Urology 2008;71:901-5.
18. Namiki S, Kwan L, Kagawa-Singer M, Tochigi T, Ioritani N, Terai A, Arai Y, Litwin MS. Sexual function following radical prostatectomy: A prospective longitudinal study of cultural differences between Japanese and American men. Prostate Cancer Prostatic Dis 2008;11:298-302.
19. Litwin MS, Hays RD, Fink A, Ganz PG, Leake B, Brook RH. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med Care 1998;36:1002-12.
20. Litwin MS. Health related quality of life in older men without prostate cancer. J Urol 1999;161:1180-4.
21. Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med 1998;13:159-66.
22. Masumori N, Tsukamoto T, Kumamoto Y, Panser LA, Rhodes T, Girman CJ, Lieber MM, Jacobsen SJ. Decline of sexual function with age in Japanese men compared with American men-results of two community-based studies. Urology 1999;54:344-5.
23. Namiki S, Ishidoya S, Kawamura S, Tochigi T, Arai Y. Quality of life among elderly men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy. J Cancer Res Clin Oncol 2010;136:379-86.
24. Robbins AS, Koppie TM, Gomez SL, Parikh-Patel A, Mills PK. Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995-2004. Cancer 2007;110:1255-63.
25. Eton DT, Lepore SJ, Helgeson VS. Early quality of life in patients with localized prostate carcinoma: An examination of treatment-related, demographic, and psychosocial factors. Cancer 2001;92:1451-9.
26. Lubeck DP, Kim H, Grossfeld G, Ray P, Penson DF, Flanders SC, Carroll PR. Health related quality of life differences between black and white men with prostate cancer: Data from the cancer of the prostate strategic urologic research endeavor. J Urol 2001;166:2281-5.
27. Takahashi M, Kai I, Hisata M, Higashi Y. Attitudes and practices of breast cancer consultations regarding sexual issues: A nationwide survey of Japanese surgeons. J Clin Oncol 2006;24:5763-8.
28. Moreira ED Jr, Brock G, Glasser DB, Nicolosi A, Laumann EO, Paik A, Wang T, Gingell C, GSSAB Investigators' Group. Help-seeking behaviour for sexual problems: The global study of sexual attitudes and behaviors. Int J Clin Pract 2005;59:6-16.
29. Banthia R, Malcarne VL, Varni JW, Ko CM, Sadler GR, Greenbergs HL. The effects of dyadic strength and coping styles on psychological distress in couples faced with prostate cancer. J Behav Med 2003;26:31-52.
30. Bergman J, Gore JL, Saigal CS, Kwan L, Litwin MS. Partnership and outcomes in men with prostate cancer. Cancer 2009;115:4688-94.
31. Gore JL, Krupski T, Kwan L, Maliski S, Litwin MS. Partnership status influences quality of life in low-income, uninsured men with prostate cancer. Cancer 2005;104:191-8.
32. Hisasue S, Kumamoto Y, Sato Y, Masumori N, Horita H, Kato R, Kobayashi K, Hashimoto K, Yamashita N, Itoh N. Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: A Japanese female cohort study. Urology 2005;65:143-8.
33. Johnson TK, Gilliland FD, Hoffman RM, Deapen D, Penson DF, Stanford JL, Albertsen PC, Hamilton AS. Racial/ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer. J Clin Oncol 2004;22:4193-201.
34. Penson DF, Litwin MS, Lubeck DP, Flanders S, Pasta DJ, Carroll PR. Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer. Prostate Cancer Prostatic Dis 1998;1:134-43.
35. Descazeaud A, Debré B, Flam TA. Age difference between patient and partner is a predictive factor of potency rate following radical prostatectomy. J Urol 2006;176:2594-8.